证券记录 · 已归档季度
REGN
Regeneron Pharmaceuticals, Inc. · Healthcare · Biotechnology
20被追踪持有人
+1Δ持有人
13.10M持有股份
$13.76B报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +5.3% ·
股份流向 -4.9% ·
净新建仓位 +5.0%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 5 | -2 | 489.34K | $362.44M | n/a | −2 |
| Q2 2026 | 169 | -1 | 76.12M | $47.53B | +5 | −5 |
| Q1 2026 | 172 | -4 | 77.87M | $60.04B | +2 | −7 |
| Q4 2025 | 175 | 0 | 81.03M | $62.54B | +1 | n/a |
| Q3 2025 | 27 | -1 | 48.96M | $27.52B | n/a | −2 |
| Q2 2025 | 26 | +2 | 40.24M | $21.12B | +3 | −1 |
| Q1 2025 | 21 | +1 | 16.62M | $10.53B | +1 | n/a |
| Q4 2024 | 20 | -1 | 17.24M | $12.28B | n/a | −1 |
| Q3 2024 | 20 | +1 | 13.10M | $13.76B | +2 | −1 |
| Q2 2024 | 19 | n/a | 13.77M | $14.47B | n/a | n/a |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 4.30M | -7.3% | $4.52B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 2 | Dodge & Cox ✦ | 2.31M | -0.2% | $2.43B | 1.4% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 2.27M | -5.9% | $2.38B | 0.2% | ▼ Trim | 2 | SEC ↗ ×2 |
| 4 | T. Rowe Price ✦ | 1.28M | +36.7% | $1.34B | 0.2% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (被动) | 1.12M | -0.4% | $1.18B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 440.61K | -58.5% | $463.19M | 0.1% | ▼ Trim | 2 | SEC ↗ ×8 |
| 7 | D. E. Shaw & Co. ✦ | 266.24K | +4.7% | $279.88M | 0.4% | ▲ Add | 2 | SEC ↗ ×2 |
| 8 | AQR Capital Management ✦ | 225.53K | +19.1% | $235.23M | 0.3% | ▲ Add | 2 | SEC ↗ ×3 |
| 9 | Renaissance Technologies ✦ | 211.42K | +14.2% | $222.26M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 10 | Millennium Management ✦ | 201.17K | -24.7% | $211.48M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 169.64K | +4.4% | $178.33M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 12 | Marshall Wace ✦ | 134.00K | +127.6% | $140.87M | 0.2% | ▲ Add | 2 | SEC ↗ ×2 |
| 13 | Citadel Advisors ✦ | 70.26K | -35.9% | $73.86M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 14 | Viking Global Investors ✦ | 49.87K | 新增 | $52.43M | 0.2% | New | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 22.39K | 新增 | $23.54M | 0.1% | New | 1 | SEC ↗ |
| 16 | ARK Investment Management ✦ | 15.15K | -4.5% | $15.93M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 5.63K | -1.3% | $5.92M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 5.06K | -10.7% | $5.32M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 557 | -89.6% | $585,541 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | GAMCO Investors ✦ | 365 | +18.9% | $383,703 | 0.0% | ▲ Add | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Viking Global Investors | $52.43M | 0.2% |
| Two Sigma Investments | $23.54M | 0.1% |
已清仓
| Point72 Asset Management | $24.04M | 曾为 0.1% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,385 持有人, 83.52M 股份, $61.43B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 14
MURPHY ANDREW J
Officer · 50 股 · $39,074
Oct 14
MURPHY ANDREW J
Officer · 127 股 · $97,701
Oct 14
MURPHY ANDREW J
Officer · 12 股 · $9,242
Oct 14
MURPHY ANDREW J
Officer · 283 股 · $218,351
Oct 14
MURPHY ANDREW J
Officer · 211 股 · $163,010
Oct 14
MURPHY ANDREW J
Officer · 224 股 · $173,242
Oct 14
MURPHY ANDREW J
Officer · 121 股 · $93,712
Oct 14
MURPHY ANDREW J
Officer · 376 股 · $291,573
Oct 14
MURPHY ANDREW J
Officer · 66 股 · $51,236
Oct 14
MURPHY ANDREW J
Officer · 38 股 · $29,555
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据